Why It Matters
Nebraska has reached a legislative milestone in its medical cannabis program, with the state Legislature passing its first-ever bill designed to operationalize a voter-approved medical cannabis framework. The passage of Legislative Bill 1235 gives the Nebraska Medical Cannabis Commission the financial and regulatory tools it needs to begin functioning — a critical step toward making medical cannabis accessible to qualifying patients across the state.
Without dedicated funding and fee-setting authority, the commission had been unable to hire staff or begin licensing the cultivators, manufacturers, and dispensaries that would eventually supply patients with the medicine they voted to access.
What Happened
The Nebraska Legislature voted 46-2 on Wednesday, April 1, 2026, to pass LB 1235, a bill led by the General Affairs Committee that establishes the foundational financial and operational structure for the Nebraska Medical Cannabis Commission. The legislation was introduced on behalf of the commission, though the commission itself took no formal position on the measure.
On the same day, lawmakers also approved LB 1071, a state budget adjustment bill, by a vote of 35-13. Together, the two bills provide the commission with its first pathway to hire dedicated staff and begin moving Nebraska’s medical cannabis program from a voter-approved concept toward a functioning regulatory system.
The commission was created following a November 2024 ballot measure that 67% of Nebraska voters passed. A separate measure passed in the same election, with 71% of voters in favor, legalized the possession of up to 5 ounces of medical cannabis for patients and caregivers who obtain a recommendation from a licensed health care practitioner.
An earlier version of LB 1235 would have expanded the commission’s authority to regulate patients, caregivers, and medical providers — powers that went beyond what the original ballot measure contemplated. Those provisions were removed before the bill advanced to its final vote.
By the Numbers
- 46-2 — Legislative vote in favor of LB 1235
- 67% — Share of Nebraska voters who approved the creation of the Medical Cannabis Commission in November 2024
- 71% — Share of voters who approved medical cannabis possession in the same election
- $12,500 — Annual salary established for each medical cannabis commissioner under the new law
- $50,000 — Maximum application fee the commission is now authorized to charge cultivators, manufacturers, and dispensaries seeking licensure
- At least 1 year — Estimated timeline before medical cannabis becomes available to patients, according to lawmakers
What the Bill Does
LB 1235 passed with four primary components related to the medical cannabis program. First, it establishes a $12,500 annual salary for the commission’s appointed members, recognizing the work involved in building a new regulatory body from the ground up.
Second, the bill creates a dedicated state cash fund where the commission can deposit legislative appropriations, application fees, grants, gifts, and other collected revenue. This fund will be used exclusively to support medical cannabis regulation.
Third, it authorizes the commission to set application fees of up to $50,000 for prospective cultivators, manufacturers, and dispensaries — a key revenue mechanism that will help sustain the program’s operations over time.
Fourth, the bill formally requires fingerprint submissions for background checks from all applicants seeking a registered medical cannabis establishment license, a process the commission had already been conducting informally.
Under current Nebraska law, medical cannabis will not be subject to state sales taxes once the product reaches patients.
Zoom Out
Nebraska’s legislative action reflects a broader national pattern in which voter-led ballot initiatives on cannabis policy have outpaced formal legislative frameworks. Across the country, states such as South Dakota and Mississippi have faced similar delays between voter approval of medical cannabis measures and the actual availability of the product, often due to funding gaps or regulatory uncertainty.
Nebraska’s decade-long debate over medical cannabis — marked by multiple failed ballot efforts before the 2024 success — underscores how contentious the issue has been in conservative-leaning legislatures even when public support is strong. The 2024 election results, with supermajority approval on both cannabis measures, gave lawmakers a clear directive that has now translated into formal legislative action.
What’s Next
The Nebraska Medical Cannabis Commission is expected to begin hiring its first dedicated staff following the budget and regulatory bill approvals. The commission will also begin developing and finalizing its fee structures and application processes for prospective cannabis establishment license holders.
Lawmakers have estimated that patients could still be approximately one year or more away from being able to access medical cannabis through licensed dispensaries. Regulatory rulemaking, the licensing process for establishments, and the buildout of the supply chain will each need to be completed before the medicine reaches patients.